Hematopoietic SCT activity in Asia: A report from the Asia-Pacific Blood and Marrow Transplantation Group

A. Yoshimi; R. Suzuki; Y. Atsuta; M. Iida; D. P. Lu; W. Tong; A. Ghavamzadeh; K. Alimoghaddam; A. K.W. Lie; R. Liang; L. L. Chan; L. Haipeng; P. L. Tan; W. Y.K. Hwang; T. J. Chiou; P. M. Chen; T. Van Binh; N. N. Minh; C. K. Min; T. J. Hwang; Y. Kodera

doi:10.1038/bmt.2010.34

Hematopoietic SCT activity in Asia: A report from the Asia-Pacific Blood and Marrow Transplantation Group

A. Yoshimi
, R. Suzuki
, Y. Atsuta
, M. Iida
, D. P. Lu
, W. Tong
, A. Ghavamzadeh
, K. Alimoghaddam
, A. K.W. Lie
, R. Liang
, L. L. Chan
, L. Haipeng
, P. L. Tan
, W. Y.K. Hwang
, T. J. Chiou
, P. M. Chen
, T. Van Binh
, N. N. Minh
, C. K. Min
, T. J. Hwang

Y. Kodera

Department of Internal Medicine

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Abstract

The hematopoietic SCT (HSCT) activity in nine Asian countries/regions was surveyed to overview the current situation. Data of 58 113 HSCTs (allogeneic: 63% vs autologous: 37%) performed between 1986 and 2006 by 432 transplant teams were collected. The number of HSCTs has been increasing in the past two decades in most countries/regions. The increase in allogeneic HSCTs is greater than in autologous HSCTs. The proportion of unrelated donors among allogeneic HSCTs in 2006 varied widely from <1% (Iran and Vietnam) to 62% (Japan). The use of each stem cell source, that is, BM, PBSC, cord blood and others (including co-infusion of BM and PBSC), also varied widely (36, 58, 0.1 and 6% in HSCT from related donors, respectively, and 53, 11, 35 and 1% in HSCT from unrelated donors, respectively). HSCTs have been continuously increasing for all indications except for chronic myelogenous leukemia and solid tumors. Hemoglobinopathy is a common indication among non-malignant diseases in many Asian countries/regions except for China, Japan and Korea. This survey clearly shows the recent progress of HSCTs in Asia and also some differences in donor and stem cell selection and disease application among countries/regions.

Original language	English
Pages (from-to)	1682-1691
Number of pages	10
Journal	Bone Marrow Transplantation
Volume	45
Issue number	12
DOIs	https://doi.org/10.1038/bmt.2010.34
State	Published - Dec 2010

Bibliographical note

Funding Information:
Coordinator: Chang-Ki Min, supported by Korea Marrow Donor Program, Catholic Hemopoietic Stem Cell Bank, and Korea Stem Cell Transplantation Nurse Association Centers: The Catholic University St Mary’s Hospital, The Catholic University Kangnam St Mary’s Hospital, The Catholic University Daejeon St Mary’s Hospital, The Catholic University Our Lady Mercy Hospital, The Catholic University St Vincent’s Hospital, Gachon University Gil Hospital, Kyungpook National University Hospital, Gyeongsan National University Hospital, Kyung Hee University Hospital, Korea University Guro Hospital, Korea University Anam Hospital, Kosin University Gospel Hospital, National Cancer Center, Daegu Catholic University Hospital, Daegu Fatima Hospital, Dong-A University Hospital, Pusan National University Hospital, Seoul National University Hospital, Sungkyunkwan University Hospital, Soonchunhyang University Bucheon Hospital, Soonchunhyang University Seoul Hospital, Ajou University Hospital, Yonsei University Hospital, Yeungnam University Hospital, Ulsan University Asan Medical Center, Ulsan University Hospital, Wonkwang University Hospital, Korea Cancer Center Hospital, Ewha Women’s Univesity Mokdong Hospital, Inje University Paik Hospital, Inha University Hospital, Chonnam National University Hwasun Hospital, Chonbuk National University Hospital, Chungnam National University Hospital, Pochon Univesity Bundang CHA Hospital, Hallym University Hospital, Hanyang University Hospital.

Keywords

Asia
hematopoietic SCT
registry

Access to Document

10.1038/bmt.2010.34

Cite this

Yoshimi, A., Suzuki, R., Atsuta, Y., Iida, M., Lu, D. P., Tong, W., Ghavamzadeh, A., Alimoghaddam, K., Lie, A. K. W., Liang, R., Chan, L. L., Haipeng, L., Tan, P. L., Hwang, W. Y. K., Chiou, T. J., Chen, P. M., Van Binh, T., Minh, N. N., Min, C. K., ... Kodera, Y. (2010). Hematopoietic SCT activity in Asia: A report from the Asia-Pacific Blood and Marrow Transplantation Group. Bone Marrow Transplantation, 45(12), 1682-1691. https://doi.org/10.1038/bmt.2010.34

@article{bab980fd4a57448682455c8388922fb7,

title = "Hematopoietic SCT activity in Asia: A report from the Asia-Pacific Blood and Marrow Transplantation Group",

abstract = "The hematopoietic SCT (HSCT) activity in nine Asian countries/regions was surveyed to overview the current situation. Data of 58 113 HSCTs (allogeneic: 63\% vs autologous: 37\%) performed between 1986 and 2006 by 432 transplant teams were collected. The number of HSCTs has been increasing in the past two decades in most countries/regions. The increase in allogeneic HSCTs is greater than in autologous HSCTs. The proportion of unrelated donors among allogeneic HSCTs in 2006 varied widely from <1\% (Iran and Vietnam) to 62\% (Japan). The use of each stem cell source, that is, BM, PBSC, cord blood and others (including co-infusion of BM and PBSC), also varied widely (36, 58, 0.1 and 6\% in HSCT from related donors, respectively, and 53, 11, 35 and 1\% in HSCT from unrelated donors, respectively). HSCTs have been continuously increasing for all indications except for chronic myelogenous leukemia and solid tumors. Hemoglobinopathy is a common indication among non-malignant diseases in many Asian countries/regions except for China, Japan and Korea. This survey clearly shows the recent progress of HSCTs in Asia and also some differences in donor and stem cell selection and disease application among countries/regions.",

keywords = "Asia, hematopoietic SCT, registry",

author = "A. Yoshimi and R. Suzuki and Y. Atsuta and M. Iida and Lu, \{D. P.\} and W. Tong and A. Ghavamzadeh and K. Alimoghaddam and Lie, \{A. K.W.\} and R. Liang and Chan, \{L. L.\} and L. Haipeng and Tan, \{P. L.\} and Hwang, \{W. Y.K.\} and Chiou, \{T. J.\} and Chen, \{P. M.\} and \{Van Binh\}, T. and Minh, \{N. N.\} and Min, \{C. K.\} and Hwang, \{T. J.\} and Y. Kodera",

note = "Funding Information: Coordinator: Chang-Ki Min, supported by Korea Marrow Donor Program, Catholic Hemopoietic Stem Cell Bank, and Korea Stem Cell Transplantation Nurse Association Centers: The Catholic University St Mary{\textquoteright}s Hospital, The Catholic University Kangnam St Mary{\textquoteright}s Hospital, The Catholic University Daejeon St Mary{\textquoteright}s Hospital, The Catholic University Our Lady Mercy Hospital, The Catholic University St Vincent{\textquoteright}s Hospital, Gachon University Gil Hospital, Kyungpook National University Hospital, Gyeongsan National University Hospital, Kyung Hee University Hospital, Korea University Guro Hospital, Korea University Anam Hospital, Kosin University Gospel Hospital, National Cancer Center, Daegu Catholic University Hospital, Daegu Fatima Hospital, Dong-A University Hospital, Pusan National University Hospital, Seoul National University Hospital, Sungkyunkwan University Hospital, Soonchunhyang University Bucheon Hospital, Soonchunhyang University Seoul Hospital, Ajou University Hospital, Yonsei University Hospital, Yeungnam University Hospital, Ulsan University Asan Medical Center, Ulsan University Hospital, Wonkwang University Hospital, Korea Cancer Center Hospital, Ewha Women{\textquoteright}s Univesity Mokdong Hospital, Inje University Paik Hospital, Inha University Hospital, Chonnam National University Hwasun Hospital, Chonbuk National University Hospital, Chungnam National University Hospital, Pochon Univesity Bundang CHA Hospital, Hallym University Hospital, Hanyang University Hospital.",

year = "2010",

month = dec,

doi = "10.1038/bmt.2010.34",

language = "English",

volume = "45",

pages = "1682--1691",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "12",

}

Yoshimi, A, Suzuki, R, Atsuta, Y, Iida, M, Lu, DP, Tong, W, Ghavamzadeh, A, Alimoghaddam, K, Lie, AKW, Liang, R, Chan, LL, Haipeng, L, Tan, PL, Hwang, WYK, Chiou, TJ, Chen, PM, Van Binh, T, Minh, NN, Min, CK, Hwang, TJ & Kodera, Y 2010, 'Hematopoietic SCT activity in Asia: A report from the Asia-Pacific Blood and Marrow Transplantation Group', Bone Marrow Transplantation, vol. 45, no. 12, pp. 1682-1691. https://doi.org/10.1038/bmt.2010.34

TY - JOUR

T1 - Hematopoietic SCT activity in Asia

T2 - A report from the Asia-Pacific Blood and Marrow Transplantation Group

AU - Yoshimi, A.

AU - Suzuki, R.

AU - Atsuta, Y.

AU - Iida, M.

AU - Lu, D. P.

AU - Tong, W.

AU - Ghavamzadeh, A.

AU - Alimoghaddam, K.

AU - Lie, A. K.W.

AU - Liang, R.

AU - Chan, L. L.

AU - Haipeng, L.

AU - Tan, P. L.

AU - Hwang, W. Y.K.

AU - Chiou, T. J.

AU - Chen, P. M.

AU - Van Binh, T.

AU - Minh, N. N.

AU - Min, C. K.

AU - Hwang, T. J.

AU - Kodera, Y.

N1 - Funding Information: Coordinator: Chang-Ki Min, supported by Korea Marrow Donor Program, Catholic Hemopoietic Stem Cell Bank, and Korea Stem Cell Transplantation Nurse Association Centers: The Catholic University St Mary’s Hospital, The Catholic University Kangnam St Mary’s Hospital, The Catholic University Daejeon St Mary’s Hospital, The Catholic University Our Lady Mercy Hospital, The Catholic University St Vincent’s Hospital, Gachon University Gil Hospital, Kyungpook National University Hospital, Gyeongsan National University Hospital, Kyung Hee University Hospital, Korea University Guro Hospital, Korea University Anam Hospital, Kosin University Gospel Hospital, National Cancer Center, Daegu Catholic University Hospital, Daegu Fatima Hospital, Dong-A University Hospital, Pusan National University Hospital, Seoul National University Hospital, Sungkyunkwan University Hospital, Soonchunhyang University Bucheon Hospital, Soonchunhyang University Seoul Hospital, Ajou University Hospital, Yonsei University Hospital, Yeungnam University Hospital, Ulsan University Asan Medical Center, Ulsan University Hospital, Wonkwang University Hospital, Korea Cancer Center Hospital, Ewha Women’s Univesity Mokdong Hospital, Inje University Paik Hospital, Inha University Hospital, Chonnam National University Hwasun Hospital, Chonbuk National University Hospital, Chungnam National University Hospital, Pochon Univesity Bundang CHA Hospital, Hallym University Hospital, Hanyang University Hospital.

PY - 2010/12

Y1 - 2010/12

N2 - The hematopoietic SCT (HSCT) activity in nine Asian countries/regions was surveyed to overview the current situation. Data of 58 113 HSCTs (allogeneic: 63% vs autologous: 37%) performed between 1986 and 2006 by 432 transplant teams were collected. The number of HSCTs has been increasing in the past two decades in most countries/regions. The increase in allogeneic HSCTs is greater than in autologous HSCTs. The proportion of unrelated donors among allogeneic HSCTs in 2006 varied widely from <1% (Iran and Vietnam) to 62% (Japan). The use of each stem cell source, that is, BM, PBSC, cord blood and others (including co-infusion of BM and PBSC), also varied widely (36, 58, 0.1 and 6% in HSCT from related donors, respectively, and 53, 11, 35 and 1% in HSCT from unrelated donors, respectively). HSCTs have been continuously increasing for all indications except for chronic myelogenous leukemia and solid tumors. Hemoglobinopathy is a common indication among non-malignant diseases in many Asian countries/regions except for China, Japan and Korea. This survey clearly shows the recent progress of HSCTs in Asia and also some differences in donor and stem cell selection and disease application among countries/regions.

AB - The hematopoietic SCT (HSCT) activity in nine Asian countries/regions was surveyed to overview the current situation. Data of 58 113 HSCTs (allogeneic: 63% vs autologous: 37%) performed between 1986 and 2006 by 432 transplant teams were collected. The number of HSCTs has been increasing in the past two decades in most countries/regions. The increase in allogeneic HSCTs is greater than in autologous HSCTs. The proportion of unrelated donors among allogeneic HSCTs in 2006 varied widely from <1% (Iran and Vietnam) to 62% (Japan). The use of each stem cell source, that is, BM, PBSC, cord blood and others (including co-infusion of BM and PBSC), also varied widely (36, 58, 0.1 and 6% in HSCT from related donors, respectively, and 53, 11, 35 and 1% in HSCT from unrelated donors, respectively). HSCTs have been continuously increasing for all indications except for chronic myelogenous leukemia and solid tumors. Hemoglobinopathy is a common indication among non-malignant diseases in many Asian countries/regions except for China, Japan and Korea. This survey clearly shows the recent progress of HSCTs in Asia and also some differences in donor and stem cell selection and disease application among countries/regions.

KW - Asia

KW - hematopoietic SCT

KW - registry

UR - https://www.scopus.com/pages/publications/78650199305

U2 - 10.1038/bmt.2010.34

DO - 10.1038/bmt.2010.34

M3 - Article

C2 - 20190847

AN - SCOPUS:78650199305

SN - 0268-3369

VL - 45

SP - 1682

EP - 1691

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 12

ER -

Hematopoietic SCT activity in Asia: A report from the Asia-Pacific Blood and Marrow Transplantation Group

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this